Fortunately, after the finding of hormone receptors (HoR) including estrogen receptor (ER) and progesterone receptor (PR), endocrine therapy was gradually becoming the standard treatment for patients with HoR-positive breast cancer and significantly improved the survival for those patients (2). This evidence concerns the gene NR4A1 and breast carcinoma.